Global Women's Health Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Women's Health

• 1.1 Definition of Women's Health
• 1.2 Women's Health Segment by Type
  • 1.2.1 Global Women's Health Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Hormonal Treatment
  • 1.2.3 Non-Hormonal Treatment
• 1.3 Women's Health Segment by Applications
  • 1.3.1 Global Women's Health Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Postmenopausal Osteoporosis
  • 1.3.3 Infertility
  • 1.3.4 Endometriosis
  • 1.3.5 Contraceptives
  • 1.3.6 Menopause
  • 1.3.7 Polycystic Ovary Syndrome (PCOS)
• 1.4 Global Women's Health Overall Market
  • 1.4.1 Global Women's Health Revenue (2014-2025)
  • 1.4.2 Global Women's Health Production (2014-2025)
  • 1.4.3 North America Women's Health Status and Prospect (2014-2025)
  • 1.4.4 Europe Women's Health Status and Prospect (2014-2025)
  • 1.4.5 China Women's Health Status and Prospect (2014-2025)
  • 1.4.6 Japan Women's Health Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Women's Health Status and Prospect (2014-2025)
  • 1.4.8 India Women's Health Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Women's Health
• 2.3 Manufacturing Process Analysis of Women's Health
• 2.4 Industry Chain Structure of Women's Health

3 Development and Manufacturing Plants Analysis of Women's Health

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Women's Health Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Women's Health
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Women's Health Production and Capacity Analysis
• 4.2 Women's Health Revenue Analysis
• 4.3 Women's Health Price Analysis
• 4.4 Market Concentration Degree

5 Women's Health Regional Market Analysis

• 5.1 Women's Health Production by Regions
  • 5.1.1 Global Women's Health Production by Regions
  • 5.1.2 Global Women's Health Revenue by Regions
• 5.2 Women's Health Consumption by Regions
• 5.3 North America Women's Health Market Analysis
  • 5.3.1 North America Women's Health Production
  • 5.3.2 North America Women's Health Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Women's Health Import and Export
• 5.4 Europe Women's Health Market Analysis
  • 5.4.1 Europe Women's Health Production
  • 5.4.2 Europe Women's Health Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Women's Health Import and Export
• 5.5 China Women's Health Market Analysis
  • 5.5.1 China Women's Health Production
  • 5.5.2 China Women's Health Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Women's Health Import and Export
• 5.6 Japan Women's Health Market Analysis
  • 5.6.1 Japan Women's Health Production
  • 5.6.2 Japan Women's Health Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Women's Health Import and Export
• 5.7 Southeast Asia Women's Health Market Analysis
  • 5.7.1 Southeast Asia Women's Health Production
  • 5.7.2 Southeast Asia Women's Health Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Women's Health Import and Export
• 5.8 India Women's Health Market Analysis
  • 5.8.1 India Women's Health Production
  • 5.8.2 India Women's Health Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Women's Health Import and Export

6 Women's Health Segment Market Analysis (by Type)

• 6.1 Global Women's Health Production by Type
• 6.2 Global Women's Health Revenue by Type
• 6.3 Women's Health Price by Type

7 Women's Health Segment Market Analysis (by Application)

• 7.1 Global Women's Health Consumption by Application
• 7.2 Global Women's Health Consumption Market Share by Application (2014-2019)

8 Women's Health Major Manufacturers Analysis

• 8.1 Agile Therapeutics
  • 8.1.1 Agile Therapeutics Women's Health Production Sites and Area Served
  • 8.1.2 Agile Therapeutics Product Introduction, Application and Specification
  • 8.1.3 Agile Therapeutics Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Allergan
  • 8.2.1 Allergan Women's Health Production Sites and Area Served
  • 8.2.2 Allergan Product Introduction, Application and Specification
  • 8.2.3 Allergan Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Amgen
  • 8.3.1 Amgen Women's Health Production Sites and Area Served
  • 8.3.2 Amgen Product Introduction, Application and Specification
  • 8.3.3 Amgen Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 AstraZeneca
  • 8.4.1 AstraZeneca Women's Health Production Sites and Area Served
  • 8.4.2 AstraZeneca Product Introduction, Application and Specification
  • 8.4.3 AstraZeneca Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Bayer AG
  • 8.5.1 Bayer AG Women's Health Production Sites and Area Served
  • 8.5.2 Bayer AG Product Introduction, Application and Specification
  • 8.5.3 Bayer AG Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Bristol-Myers Squibb Company
  • 8.6.1 Bristol-Myers Squibb Company Women's Health Production Sites and Area Served
  • 8.6.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.6.3 Bristol-Myers Squibb Company Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Ferring
  • 8.7.1 Ferring Women's Health Production Sites and Area Served
  • 8.7.2 Ferring Product Introduction, Application and Specification
  • 8.7.3 Ferring Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Merck
  • 8.8.1 Merck Women's Health Production Sites and Area Served
  • 8.8.2 Merck Product Introduction, Application and Specification
  • 8.8.3 Merck Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Pfizer
  • 8.9.1 Pfizer Women's Health Production Sites and Area Served
  • 8.9.2 Pfizer Product Introduction, Application and Specification
  • 8.9.3 Pfizer Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Teva
  • 8.10.1 Teva Women's Health Production Sites and Area Served
  • 8.10.2 Teva Product Introduction, Application and Specification
  • 8.10.3 Teva Women's Health Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Women's Health Market

• 9.1 Global Women's Health Market Trend Analysis
  • 9.1.1 Global Women's Health Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Women's Health Regional Market Trend
  • 9.2.1 North America Women's Health Forecast 2019-2025
  • 9.2.2 Europe Women's Health Forecast 2019-2025
  • 9.2.3 China Women's Health Forecast 2019-2025
  • 9.2.4 Japan Women's Health Forecast 2019-2025
  • 9.2.5 Southeast Asia Women's Health Forecast 2019-2025
  • 9.2.6 India Women's Health Forecast 2019-2025
• 9.3 Women's Health Market Trend (Product Type)
• 9.4 Women's Health Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Women's Health Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List